Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

Verve Therapeutics Statistics

Total Valuation

NSE:SUNPHARMA has a market cap or net worth of INR 4.09 trillion. The enterprise value is 3.86 trillion.

Market Cap	4.09T
Enterprise Value	3.86T

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	Jul 7, 2025

Share Statistics

NSE:SUNPHARMA has 2.40 billion shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	2.40B
Shares Outstanding	2.40B
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	12.01%
Owned by Institutions (%)	28.41%
Float	1.04B

Valuation Ratios

The trailing PE ratio is 39.46 and the forward PE ratio is 36.98. NSE:SUNPHARMA's PEG ratio is 3.32.

PE Ratio	39.46
Forward PE	36.98
PS Ratio	7.61
PB Ratio	5.65
P/TBV Ratio	7.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	3.32

Enterprise Valuation

EV / Earnings	37.22
EV / Sales	7.18
EV / EBITDA	24.95
EV / EBIT	29.78
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.03
Debt / EBITDA	0.15
Debt / FCF	n/a
Interest Coverage	53.04

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	11.17%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	12.51M
Profits Per Employee	2.41M
Employee Count	43,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:SUNPHARMA has paid 30.90 billion in taxes.

Income Tax	30.90B
Effective Tax Rate	22.91%

Stock Price Statistics

The stock price has decreased by -5.21% in the last 52 weeks. The beta is 0.36, so NSE:SUNPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-5.21%
50-Day Moving Average	1,680.73
200-Day Moving Average	1,744.86
Relative Strength Index (RSI)	36.19
Average Volume (20 Days)	2,156,203

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:SUNPHARMA had revenue of INR 537.77 billion and earned 103.72 billion in profits. Earnings per share was 43.25.

Revenue	537.77B
Gross Profit	420.79B
Operating Income	129.75B
Pretax Income	134.87B
Net Income	103.72B
EBITDA	153.39B
EBIT	129.75B
Earnings Per Share (EPS)	43.25

Balance Sheet

The company has 261.23 billion in cash and 23.62 billion in debt, giving a net cash position of 237.61 billion or 99.03 per share.

Cash & Cash Equivalents	261.23B
Total Debt	23.62B
Net Cash	237.61B
Net Cash Per Share	99.03
Equity (Book Value)	724.86B
Book Value Per Share	300.99
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 78.25%, with operating and profit margins of 24.13% and 19.29%.

Gross Margin	78.25%
Operating Margin	24.13%
Pretax Margin	25.08%
Profit Margin	19.29%
EBITDA Margin	28.52%
EBIT Margin	24.13%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 16.00, which amounts to a dividend yield of 0.94%.

Dividend Per Share	16.00
Dividend Yield	0.94%
Dividend Growth (YoY)	18.52%
Years of Dividend Growth	6
Payout Ratio	36.99%
Buyback Yield	-0.00%
Shareholder Yield	0.92%
Earnings Yield	2.53%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.

Last Split Date	Jul 29, 2013
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	2